Open AccessIchthyosiform eruption associated with lamivudine in a patient with chronic hepatitis‐B infection
Author(s) -
Kaptanoglu A. F.,
Kutluay L.
Publication year - 2005
Publication title -
international journal of clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.756
H-Index - 98
eISSN - 1742-1241
pISSN - 1368-5031
DOI - 10.1111/j.1368-5031.2005.00618.x
Subject(s) - lamivudine , medicine , dermatology , angioedema , hepatitis b , chronic hepatitis , immunology , virus
Summary The side‐effects of antiretroviral agents have been widely reported in the literature. Lamivudine is an antiretroviral agent, and skin eruption because of this agent has been rarely reported. Previous reports regarding these few side‐effects of lamivudine include angioedema, urticaria, anaflactoid reactions, allergic contact dermatitis and alopecia. There is no report of an ichthyosiform eruption associated with lamivudine. The authors present a case of 43‐year‐old female patient presenting with an ichthyosiform eruption during lamivudine therapy for chronic hepatitis‐B for the first time.